VICTORY CAPITAL MANAGEMENT INC

Position in TYRA — Tyra Biosciences, Inc.

CIK 1040188 San Antonio, TX

Position in TYRA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$4,873,564

+$4,290,255 QoQ

Shares Held

152,585

+901.9% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 169 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. TYRA ranks #41 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,873,564	152,585	+901.9%	Shares	Sole	2026-08-07
2026-03-31	$583,309	15,230	-18.9%	Shares	Sole	2026-05-15
2025-12-31	$493,989	18,790	0.0%	Shares	Sole	2026-02-13
2025-09-30	$262,872	18,790	-57.5%	Shares	Sole	2025-11-12
2025-06-30	$422,898	44,190	-21.3%	Shares	Sole	2025-08-13
2025-03-31	$522,195	56,150	-0.9%	Shares	Sole	2025-05-02
2024-12-31	$787,296	56,640	+88.3%	Shares	Sole	2025-02-06
2024-09-30	$707,180	30,080	-36.2%	Shares	Sole	2024-11-05
2024-06-30	$754,088	47,160	-1.9%	Shares	Sole	2024-08-05
2024-03-31	$788,676	48,090	-4.2%	Shares	Sole	2024-05-03
2023-12-31	$695,547	50,220	+53.4%	Shares	Sole	2024-02-05
2023-09-30	$450,692	32,730	-1.1%	Shares	Sole	2023-11-06
2023-06-30	$563,522	33,090	-2.0%	Shares	Sole	2023-07-27
2023-03-31	$542,523	33,760	—	Shares	Sole	2023-05-02
No filing history on record for this holder in this stock.